BB Pureos Bioventures
Overview
Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug fo…
Investment Focus
- Innovative drug development companies
- Focus on novel biological drugs and emerging modalities
- Early-stage companies
- Global investment scope with emphasis on Switzerland and Europe
Portfolio Companies
Reach BB Pureos Bioventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about BB Pureos Bioventures
What sectors does BB Pureos Bioventures invest in?
BB Pureos Bioventures invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Pfäffikon Zh, Switzerland. BB Pureos Bioventures is listed as a vc in the ConnectSafely investor database.
What stage does BB Pureos Bioventures invest at?
BB Pureos Bioventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does BB Pureos Bioventures invest in?
BB Pureos Bioventures invests across United States, United Kingdom, Germany, France, Italy and Denmark.
What companies has BB Pureos Bioventures invested in?
BB Pureos Bioventures's portfolio includes Alentis Therapeutics AG, AM-Pharma BV, Eyevensys SAS, Imcheck Therapeutics SAS, Lava Therapeutics BV, NovaGo Therapeutics AG and Vico Therapeutics BV.
How do I contact BB Pureos Bioventures?
BB Pureos Bioventures's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
